Nippon Shinyaku Co., Ltd. (TYO:4516)

Japan · Delayed Price · Currency is JPY

3,396.00

-23.00 (-0.67%)

Nov 13, 2026, 3:30 PM JST

Market Cap	228.89B +1.7%
Revenue (ttm)	180.29B +12.2%
Net Income	31.56B +3.4%
EPS	468.47 +3.3%
Shares Out	67.40M
PE Ratio	7.25
Forward PE	10.41
Dividend	124.00 (3.65%)
Ex-Dividend Date	Mar 30, 2027

Volume	514,200
Open	3,429.00
Previous Close	3,419.00
Day's Range	3,350.00 - 3,476.00
52-Week Range	3,302.00 - 6,529.00
Beta	-0.34
Analysts	Hold
Price Target	3,406.25 (+0.3%)
Earnings Date	Nov 13, 2026

About Nippon Shinyaku

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Europe, Switzerland, the United States, and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Atthena Therapeutics, Inc. to develop ATSN-101 that is in Phase I/II of c... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1911

Employees 2,309

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4516

Full Company Profile

Financial Performance

In fiscal year 2026, Nippon Shinyaku's revenue was 170.77 billion, an increase of 6.58% compared to the previous year's 160.23 billion. Earnings were 29.71 billion, a decrease of -8.76%.

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for 4516 stock is "Hold." The 12-month stock price target is ¥3,406, which is an increase of 0.30% from the latest price.

Price Target

¥3,406

(0.30% upside)

Analyst Consensus: Hold

Stock Forecasts